Polivy 140 MG vials
Ended Awarded
- Contract number
- SPE2DB25FXD61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,046
Award facts
- Contract value 100% obligated
- $22,046.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,046.06 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with a completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Polivy (polatuzumab vedotin) is a CD79b-directed cytotoxic immunoconjugate used in the treatment of certain B-cell lymphomas, representing a specialized pharmaceutical product within the agency's medical procurement portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's extensive federal contract portfolio and demonstrated capability to compete and perform across diverse medical commodity requirements reinforces its critical role in the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FXD61?
SPE2DB25FXD61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FXD61 worth?
The government has obligated $22,046 on SPE2DB25FXD61.
Is contract SPE2DB25FXD61 an order under another contract?
Yes. SPE2DB25FXD61 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXD61 competed?
The extent of competition for SPE2DB25FXD61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award